Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation
Go back to Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation| (NASDAQ: CMND) | Delayed: 2.99 -0.08 (2.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.07 | 52 Week High | $ | |||
| Open | $3.08 | 52 Week Low | $ | |||
| Day High | $3.11 | P/E | N/A | |||
| Day Low | $2.96 | EPS | $ | |||
| Volume | 240,214 | |||||
| (NASDAQ: PLRZ) | Delayed: 13.20 -0.22 (1.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.42 | 52 Week High | $ | |||
| Open | $13.01 | 52 Week Low | $ | |||
| Day High | $13.39 | P/E | N/A | |||
| Day Low | $12.99 | EPS | $ | |||
| Volume | 7,396 | |||||
